Navigation Links
ASNC Names Rob Beanlands, MD, FRCP(C), FASNC, as President for 2019
Date:1/10/2019

Dr. Beanlands is the Vered Chair and Division Head of Cardiology at the University of Ottawa Heart Institute in Ottawa, Ontario, Canada. He is also Director of its National Cardiac PET Centre, and Professor in the University's Division of Cardiology in the Department of Medicine, in the Department of Radiology, and in the Department of Cellular and Molecular medicine.

He is a founding member of ASNC, member of its Board of Directors and longtime associate editor of the Journal of Nuclear Cardiology. He has served on the education, finance, audit and quality committees; and ASNC's PET Task Force, appearing as featured faculty at several education programs. He has also served as Program Chair and Vice Program Chair of ASNC’s Annual Scientific Session in 2011 and 2012, respectively.

During his tenure as president, Dr. Beanlands will focus on appropriate use criteria, maximizing the value of nuclear cardiology testing to provide high quality, cost-effective cardiac care and member leadership development and expanding ASNC’s international footprint. A key part of his mission is to educate the cardiovascular imaging community, including referring physicians, on the expanding applications of nuclear cardiology such as cardiac amyloidosis and the important role to diagnose and prognosticate the disease; and increase positron emission tomography (PET) training through workshops and online curriculum demonstrating best practices for blood flow measurements. In addition, he will continue to expand and utilize data from the ImageGuide Registry®, the nation’s first cardiovascular nuclear imaging data registry and Qualified Clinical Data Registry (QCDR), to improve laboratory quality and efficiency, optimize patient radiation exposure, minimize downstream costs and improve patient care and safety.

He is enthusiastic about the evolution of multimodality imaging and nuclear cardiology's role in patient management to guide therapy. “The key aspect [of nuclear cardiology] is in the guiding therapy,” he says. “As new therapies emerge so, too, will follow the strength of nuclear imaging, which enables the understanding of biological processes in the heart and the vasculature. This helps us to decide the treatments for patients that may improve their outcomes.” Nuclear cardiology studies continue to play an increasingly important role in the new millennium, in the noninvasive diagnosis of coronary artery disease, the assessment of the pumping function of the heart and in the prediction of outcomes in patients with heart disease.

In this video, Dr. Beanlands shares his insights about the future of nuclear cardiology and the important initiatives underway at ASNC.

About the American Society of Nuclear Cardiology
For over 25 years, the American Society of Nuclear Cardiology and its more than 4,300 members have been improving cardiovascular outcomes through image-guided patient management. As the only society dedicated solely to the field of nuclear cardiology, ASNC establishes standards for excellence in cardiovascular imaging through the development of clinical guidelines, professional medical education, advocacy and research development. ASNC provides peer-reviewed original articles through its Journal of Nuclear Cardiology and operates the nation’s first noninvasive cardiac imaging registry, ImageGuide Registry®, to benchmark quality and improve patient care.
For more information, visit http://www.asnc.org.

Read the full story at https://www.prweb.com/releases/asnc_names_rob_beanlands_md_frcpc_fasnc_as_president_for_2019/prweb16020271.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology news :

1. Iris Biometrics Leader EyeLock Joins the FIDO Alliance to Help Identify More Secure Replacement for Usernames and Passwords
2. Entomological Society of America names winners of 2013 student travel grants
3. Entomological Society of America names winners of Monsanto student travel and research awards
4. Next-generation global e-infrastructure for taxon names registry
5. ACS Infectious Diseases: Unique chemistry journal names editor
6. The Brain & Behavior Research Foundation names winners of Klerman and Freedman Prizes
7. ACS Biomaterials Science & Engineering: Brand-new journal launches in 2015, names editor
8. ESA Certification Corporation names winners of 2104 awards
9. NXT-ID, Inc. Names Vice-President and Chief Financial Officer
10. C-Labs Names Former Microsoft and Bsquare Executive as Chief Operating Officer
11. The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2018)... ... December 21, 2018 , ... ... and hosted the Boston Healthcare Drinks event featuring Helen Chen, Greater China Managing ... China.” , The discussion was moderated by patent attorney David J. Dykeman ...
(Date:12/19/2018)... (PRWEB) , ... December 19, 2018 , ... InTouchMD’s flagship ... innovative products in healthcare for 2018. , PM360 is featuring the recognition in ... products and services offered to the pharmaceutical and medical device industries. , “This ...
(Date:12/18/2018)... ... December 18, 2018 , ... ... cancers and other serious diseases, today announced the publication of an early feasibility ... treatment of rGBM. , The publication of the study, An Early Feasibility ...
Breaking Biology News(10 mins):
(Date:1/7/2019)... ... January 07, 2019 , ... Kainos Medicine Inc. today announced ... candidate, code-named "KM-819." KM-819 is an orally active small molecule that is ... Korea. , This Phase 1 randomized, double-blind, placebo-controlled dose-escalation study was to ...
(Date:12/20/2018)... ... December 20, 2018 , ... New Year’s brings reflection and desire to improve ... the European Union (EU) on the horizon, Jim Kasic, president and CEO of Boulder ... the EU Medical Device Regulation (MDR), digital health, and big data are just a ...
(Date:12/18/2018)... ... ... Patients with early stages of breast cancer who undergo partial breast proton ... irradiation, a new study suggests. , Patients with early stage breast cancer — stage ... the cancerous tumor because there is a 30 to 40 percent change the disease ...
(Date:12/13/2018)... ... December 13, 2018 , ... Microbial Discovery Group LLC (MDG) ... been part of their strategic plan and an important milestone in increasing their ... opportunities for MDG within the $44 Billion human probiotic market. This plan is ...
Breaking Biology Technology: